Table 1.
Search terms.
Category | MeSH terms | Keywords (in title or abstract) |
Brexit | European Union, United Kingdom | Brexit OR United Kingdom OR Britain OR ((“EU” OR “European Union”) AND “single market”) OR “Article 50” OR ((leave OR withdraw* OR exit OR remain OR stay) ADJ4 (“European Union” OR “EU” OR “EEA” OR “European Economic Area”)) OR “Post-Brexit” |
Pharmaceuticals | Drug industry, pharmaceutical preparations, pharmaceutical societies, pharmaceutical economics, drug approval, United States Food and Drug Administration | ((Pharma* OR drug* or medic*) ADJ4 (industr* OR compan* OR supply OR sector OR production OR approval OR deliver* OR regulat* OR preparation* OR societ* OR econom* OR manufactur* OR shortage* OR stockpil* OR stock-pil*)) OR “EMA” OR “European Medicines Agency” OR “MHRA” OR “Medicines and Health products Regulatory Agency” OR “FDA” OR “Food and Drug Administration” OR “Royal Pharmaceutical Society” OR “National Health Service” OR “NHS” OR “Department of Health” |
Effects | Cost and cost analyses, time-to-treatment | Consequence* OR change* OR outcome* OR effect* OR implication* OR result* OR opinion* OR cost* OR delay* OR “customs union” OR “free trade” OR “severe” OR “severity” |